Pharmaceutical combination for curing acute radiation dermatitis

Abstract

The invention discloses a pharmaceutical composition for treating acute radiodermatitis, and comprises polyriboinosinic -polyribocytidylic acid 10-20mg, vitamin A 20,000-50,000IU and oryzanol 10-100mg. The above ingredients can be prepared into 50ml solution with a proper amount of distilled water and ethanol. Through clinic experiments, it is proved that the inventive composition can be used for treating acute radiodermatitis while continuing conducing radiotherapy, so as to ensure the anticipated tumor treatment effect, and also has therapeutic effect on chronic radiodermatitis. The inventive pharmaceutical composition has only therapeutic action on diseased tissues and has no any damage to healthy tissues; has antiphlogistic, antiallergic, radioactive rays resisting, analgesic, antipruritic and skin growth promoting effects; and has the advantages of no sedatives, no analgesics, no hormones, quick action, high cure rate, no recurrence, and no toxic or side effects.

Description

technical field [0001] The invention relates to a medicine, especially a medicine composition for treating acute radiation dermatitis. Background technique [0002] Radiation dermatitis, also known as skin radiation damage or radiation burn, refers to various types of ionizing radiation, including microparticle waves or electronic waves, acting on the surface of the human body, causing any visible early or late lesions on the skin and its appendages, which can be divided into acute and There are two types of chronic radiation dermatitis. Acute radiation dermatitis refers to the acute skin injury caused by local exposure to one or multiple large doses of external radiation (X, γ, β rays) within a short period of time (several days). Early manifestations: slight skin pigmentation, erythema, itching, pain or edema. Late manifestations: exudation, blisters, erosions, ulcers or necrosis. According to the diagnostic criteria of GBZ106-2002 radiation skin disease, it can be divi...

AI Technical Summary

Problems solved by technology

However, none of them clearly reported on the continuation of radiation therapy while treating acute radiation dermatitis.

For tumor patients, if the problem of continuing radiation therapy cannot be solved while treating acute radiation dermatitis, the expectation for tumor treatment is very slim